Ning Wen, Yibin Zhang, Haoran Zhang, Maochen Zhang, Jingjie Zhou, Yanfang Liu, Can Liao, Lecheng Jia, Kang Zhang, Jiayi Chen
{"title":"A Dual Energy CT-Guided Intelligent Radiation Therapy Platform.","authors":"Ning Wen, Yibin Zhang, Haoran Zhang, Maochen Zhang, Jingjie Zhou, Yanfang Liu, Can Liao, Lecheng Jia, Kang Zhang, Jiayi Chen","doi":"10.1016/j.ijrobp.2025.01.028","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The integration of advanced imaging and artificial intelligence (AI) technologies in radiotherapy has revolutionized cancer treatment by enhancing precision and adaptability. This study introduces a novel Dual Energy CT (DECT)-Guided Intelligent Radiation Therapy (DEIT) platform designed to streamline and optimize the radiotherapy process. The DEIT system combines DECT, a newly designed dual-layer multi-leaf collimator, deep learning algorithms for auto-segmentation, automated planning and QA capabilities.</p><p><strong>Methods: </strong>The DEIT system integrates an 80-slice CT scanner with an 87 cm bore size, a linear accelerator delivering four photon and five electron energies, and a flat panel imager optimized for MV Cone Beam CT acquisition. A comprehensive evaluation of the system's accuracy was conducted using end-to-end tests. Virtual monoenergetic CT images and electron density images of the DECT were generated and compared on both phantom and patient. The system's auto-segmentation algorithms were tested on five cases for each of the 99 organs at risk, and the automated optimization and planning capabilities were evaluated on clinical cases.</p><p><strong>Results: </strong>The DEIT system demonstrated systematic errors of less than 1 mm for target localization. DECT reconstruction showed electron density mapping deviations ranging from -0.052 to 0.001, with stable HU consistency across monoenergetic levels above 60 keV, except for high-Z materials at lower energies. Auto-segmentation achieved dice similarity coefficients above 0.9 for most organs with inference time less than 2 seconds. Dose-volume histogram (DVH) comparisons showed improved dose conformity indices and reduced doses to critical structures in Auto-plans compared to Manual Plans across various clinical cases. Additionally, high gamma passing rates at 2%/2mm in both 2D (above 97%) and 3D (above 99%) in vivo analyses further validate the accuracy and reliability of treatment plans.</p><p><strong>Conclusions: </strong>The DEIT platform represents a viable solution for radiation treatment. The DEIT system utilizes AI-driven automation, real-time adjustments, and CT imaging to enhance the radiotherapy process, improving both efficiency and flexibility.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2025.01.028","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: The integration of advanced imaging and artificial intelligence (AI) technologies in radiotherapy has revolutionized cancer treatment by enhancing precision and adaptability. This study introduces a novel Dual Energy CT (DECT)-Guided Intelligent Radiation Therapy (DEIT) platform designed to streamline and optimize the radiotherapy process. The DEIT system combines DECT, a newly designed dual-layer multi-leaf collimator, deep learning algorithms for auto-segmentation, automated planning and QA capabilities.
Methods: The DEIT system integrates an 80-slice CT scanner with an 87 cm bore size, a linear accelerator delivering four photon and five electron energies, and a flat panel imager optimized for MV Cone Beam CT acquisition. A comprehensive evaluation of the system's accuracy was conducted using end-to-end tests. Virtual monoenergetic CT images and electron density images of the DECT were generated and compared on both phantom and patient. The system's auto-segmentation algorithms were tested on five cases for each of the 99 organs at risk, and the automated optimization and planning capabilities were evaluated on clinical cases.
Results: The DEIT system demonstrated systematic errors of less than 1 mm for target localization. DECT reconstruction showed electron density mapping deviations ranging from -0.052 to 0.001, with stable HU consistency across monoenergetic levels above 60 keV, except for high-Z materials at lower energies. Auto-segmentation achieved dice similarity coefficients above 0.9 for most organs with inference time less than 2 seconds. Dose-volume histogram (DVH) comparisons showed improved dose conformity indices and reduced doses to critical structures in Auto-plans compared to Manual Plans across various clinical cases. Additionally, high gamma passing rates at 2%/2mm in both 2D (above 97%) and 3D (above 99%) in vivo analyses further validate the accuracy and reliability of treatment plans.
Conclusions: The DEIT platform represents a viable solution for radiation treatment. The DEIT system utilizes AI-driven automation, real-time adjustments, and CT imaging to enhance the radiotherapy process, improving both efficiency and flexibility.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.